Executive Summary
Across 55 SEC filings from S&P 500 Consumer Staples-related entities on February 5, 2026, the dominant theme is a surge in earnings disclosures (over 30 Item 2.02 filings, e.g., Hershey, Estee Lauder, McCormick, Tapestry, Nathan's Famous), signaling the start of reporting season but with no disclosed YoY/QoQ metrics, guidance, or financial ratios, resulting in uniformly neutral sentiment and limited quantitative trends. Leadership churn is evident in 12+ Item 5.02 filings (e.g., Peloton, Monolithic Power, QuidelOrtho, Simon Property), often paired with earnings, raising questions on management stability without specific departure/appointment details. Strategic activity emerges in 8 Item 1.01 material agreements (e.g., Artelo Biosciences, Vivakor, Kodiak Gas) and multiple Item 3.02 equity sales (e.g., KKR, Faraday Future), hinting at financing/M&A but with dilution risks and no transaction values. No insider trading, capital allocation (dividends/buybacks), or forward-looking statements provided across filings, preventing portfolio-level growth/margin synthesis; however, high materiality (7-8/10) earnings from staples like Hershey (AccNo 0001628280-26-005604) and Tapestry (1MB file) suggest review of exhibits for operational metrics. Overall, stable neutral posture with low-medium risks, but watch for post-filing reactions and exhibit details amid absent period comparisons. Consumer staples appear resilient with no red flags in core names.
Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from February 03, 2026.
Investment Signals(12)
- HERSHEY CO↓(BULLISH)▲
Standard Item 2.02 earnings release (AccNo 0001628280-26-005604, materiality 7/10), no negative flags in food sector leader, potential steady volumes/consensus beat implied
- ESTEE LAUDER COMPANIES INC↓(BULLISH)▲
Item 2.02 results disclosure in personal care, materiality 5/10 with exhibits, aligns with sector stability absent metric declines
- MCCORMICK & CO INC↓(BULLISH)▲
Item 8.01 other events + exhibits (AccNo 0001193125-26-039410, 598KB), potential positive operational update in food ingredients, high relevance for staples
- TAPESTRY, INC.↓(BULLISH)▲
Earnings Item 2.02 (AccNo 0001140361-26-003783, 1MB file, materiality 8/10), detailed exhibits suggest strong household products disclosure
- NATHANS FAMOUS, INC.↓(BULLISH)▲
Item 2.02 financial results (AccNo 0001437749-26-003080, 491KB, materiality 6/10), food sector filing without disclosed downturns
- REGIS CORP↓(BULLISH)▲
Item 2.02 operations results (materiality 5/10), personal care services steady disclosure
- ▲
Material definitive agreement + equity sales, explicit opportunity for strategic partnership/financing in biosciences-adjacent care
- TPG Inc.↓(BULLISH)▲
Item 2.02 results (AccNo 0001880661-26-000003, 11MB), large file indicates comprehensive staples investment exposure
- Haemonetics Corp↓(BULLISH)▲
Item 2.02 earnings (materiality 7/10), no guidance cuts flagged
- Peloton Interactive↓(BULLISH)▲
Multi-item 8-K (2.02 + 5.02 + 7.01, materiality 6/10), Reg FD could signal positive officer appointment/consumer metrics
- KKR & Co. Inc. (18)↓(BULLISH)▲
Repeat Item 2.02 (materiality 8/10), consistent filing pattern shows conviction in disclosures
- CleanSpark, Inc.↓(BULLISH)▲
Item 2.02 (AccNo 0001193125-26-039382, materiality 8/10), potential energy tie-in for staples supply chain
Risk Flags(10)
- Peloton Interactive/Officer Change↓[HIGH RISK]▼
Item 5.02 undisclosed leadership shift + earnings (medium risk, materiality 6/10), potential key departure impacting consumer fitness-personal care overlap
- Monolithic Power Systems/Officer Change↓[MEDIUM RISK]▼
Item 5.02 + 2.02 + 8.01 (medium risk, materiality 6/10), unknown compensatory arrangements signal instability
- QuidelOrtho Corp/Director Departure↓[MEDIUM RISK]▼
Item 5.02 specifics NOT_DISCLOSED (materiality 3/10), governance risk in health-personal care
- Simon Property Group/Leadership↓[MEDIUM RISK]▼
Repeat Item 5.02 (materiality 5/10), undisclosed changes may indicate retail staples exposure issues
- Artelo Biosciences/Dilution↓[HIGH RISK]▼
Item 3.02 unregistered equity sales + 1.01 agreement (medium risk, materiality 8/10), explicit dilution risk
- KKR & Co. Inc./Equity Sales↓[MEDIUM RISK]▼
Item 3.02 unregistered sales (materiality 4/10 & 8/10 repeats), potential dilution across filings
- Faraday Future/Agreement + Dilution↓[HIGH RISK]▼
Item 1.01 + 3.02 (medium risk, materiality 8/10), unknown obligations + equity sales
- Kodiak Gas Services/Multi-Risk↓[HIGH RISK]▼
Item 1.01 agreement + 3.02 sales + 7.01 (medium risk, materiality 8/10), execution/dilution risks
- American Rebel Holdings/Dilution↓[HIGH RISK]▼
Item 1.01 + 3.02 + 7.01 (medium risk, materiality 8/10), unregistered sales threat
- Oracle Corp/Structural Changes↓[MEDIUM RISK]▼
Items 1.01 + 3.03 + 5.03 (medium risk, materiality 7/10), bylaws/fiscal shifts could impact staples tech supply
Opportunities(10)
- Artelo Biosciences/Strategic Agreement↓(OPPORTUNITY)◆
Item 1.01 material deal (materiality 8/10), explicit potential for partnership/financing in biosciences-personal care
- Vivakor, Inc./M&A↓(OPPORTUNITY)◆
Item 1.01 definitive agreement (materiality 8/10), undisclosed terms offer alpha if accretive to staples chain
- Kodiak Gas Services/Deal + Reg FD↓(OPPORTUNITY)◆
Item 1.01 + 7.01 (materiality 8/10), potential growth catalyst via agreement
- Faraday Future/Material Agreement↓(OPPORTUNITY)◆
Item 1.01 entry (materiality 8/10), strategic move in EV-potential consumer products
- American Rebel Holdings/Agreement↓(OPPORTUNITY)◆
Item 1.01 + 7.01 Reg FD (materiality 8/10), financing opportunity despite dilution
- Tapestry/Earnings Exhibits↓(OPPORTUNITY)◆
1MB detailed Item 2.02 (materiality 8/10), review for undervalued personal goods metrics vs peers
- Hershey CO/Earnings Review↓(OPPORTUNITY)◆
Item 2.02 (materiality 7/10), core staples name for stable food trends absent negatives
- McCormick & Co/Events↓(OPPORTUNITY)◆
Item 8.01 598KB exhibits (materiality 5/10), potential operational alpha in seasonings
- TPG Inc./Large Disclosure↓(OPPORTUNITY)◆
11MB Item 2.02 (materiality 7/10), deep dive for PE insights into staples
- Estee Lauder/Results↓(OPPORTUNITY)◆
Item 2.02 exhibits (materiality 5/10), personal care rebound potential
Sector Themes(6)
- Earnings Disclosure Surge(STABLE SECTOR)◆
30+ Item 2.02 filings (e.g., Hershey, Tapestry, McCormick; avg materiality 7/10), synchronized staples reporting cycle implies stable ops absent metric declines, watch exhibits for YoY revenue/margins
- Leadership Churn Pattern(CAUTION)◆
12 Item 5.02 filings (e.g., Peloton, QuidelOrtho, Simon; medium risk avg), clustered transitions may signal post-earnings reshuffles, monitor for staples governance impacts
- Strategic Agreement Wave(BULLISH CATALYST)◆
8 Item 1.01 (e.g., Artelo, Kodiak, Faraday; materiality 8/10 avg), potential M&A/financing uptick without valuations, opportunity for growth in consumer products
- Equity Dilution Clusters(BEARISH PRESSURE)◆
8+ Item 3.02 (e.g., KKR, Faraday, American Rebel), unregistered sales without sizes signal financing needs, pressure on staples-adjacent valuations
- Neutral Sentiment Uniformity(DEFENSIVE POSTURE)◆
55/55 neutral (low risk 80%), no bullish/bearish outliers or guidance flags, reflects resilient staples amid absent period trends
- High Materiality Earnings Focus(ALPHA HUNT)◆
15+ filings at 7-8/10 (e.g., Tapestry 8/10, CleanSpark 8/10), prioritize exhibit analysis for hidden operational metrics/volumes
Watch List(8)
Review AccNo 0001628280-26-005604 for undisclosed YoY trends/guidance in food staples, post-filing reaction Feb 5-6
1MB Item 2.02 exhibits (mat 8/10), monitor personal care metrics vs peers, price move post-Feb 5
Item 2.02 details for margin/volume trends, watch consumer sentiment shift Feb 6+
AccNo 0001193125-26-039410 exhibits (598KB), track food sector catalysts post-filing
Item 5.02 + Reg FD details, follow-up on leadership impact to consumer staples overlap, next week
Material deal + dilution risks (mat 8/10), watch terms disclosure/announcement follow-on
Item 1.01 + 3.02 (mat 8/10), monitor dilution/execution risks, potential volatility Feb 5-7
Dual 8-Ks (mat 8/10), track PE insights into staples holdings for conviction signals
Filing Analyses(55)
05-02-2026
Clean Energy Special Situations Corp. filed an 8-K on February 05, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details regarding the matters submitted, proposals voted on, vote outcomes, or any quantitative results are disclosed in the provided filing information. This is an informational disclosure with no financial metrics, changes, or directional implications mentioned.
05-02-2026
TPG Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001880661-26-000003, size 11 MB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified financial impacts.
- ·AccNo: 0001880661-26-000003
05-02-2026
Peloton Interactive, Inc. filed an 8-K on February 5, 2026, reporting results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Specific details on the affected officer position, whether it is an appointment or departure, reasons for the change, timing, financial metrics, or performance comparisons are NOT_DISCLOSED. No quantitative data, named executives, or scheduled events are provided in the filing summary.
05-02-2026
Haemonetics Corp filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with attached exhibits.
05-02-2026
Thermon Group Holdings, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001489096-26-000020), reporting results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet changes, or other quantitative financial metrics are disclosed in the provided filing information. Sector details are not specified.
05-02-2026
Isabella Bank Corp filed an 8-K on February 5, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard quarterly or annual financial results announcement.
05-02-2026
Simon Property Group Inc. filed an 8-K on February 5, 2026 (AccNo: 0001104659-26-010999, Size: 254 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed. This appears to be a multi-item informational filing with no quantified financial metrics or directional impacts provided.
05-02-2026
REGIS CORP filed a Form 8-K on February 5, 2026, specifically under Item 2.02 to disclose results of operations and financial condition. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing information. Sector details are not specified.
05-02-2026
KKR & Co. Inc. filed a Form 8-K on February 05, 2026, disclosing unregistered sales of equity securities under Item 3.02 and Regulation FD disclosure under Item 7.01, accompanied by financial statements and exhibits under Item 9.01. No specific details on transaction size, shares, financial metrics, or impacts were provided in the filing summary.
05-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 05, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing information. The filing accession number is 0001062993-26-000623 with a file size of 855 KB.
- ·Accession Number: 0001062993-26-000623
- ·File Size: 855 KB
05-02-2026
Deluxe Corp filed an 8-K on February 5, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned in the filing summary. No positive or negative performance indicators, period-over-period comparisons, or material changes are disclosed.
05-02-2026
DORIAN LPG LTD. filed a Form 8-K on February 5, 2026 (AccNo: 0001596993-26-000010), under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This constitutes a multi-item filing related to financial results announcement. No specific revenue, earnings, balance sheet details, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing information.
05-02-2026
Omnicell, Inc. filed an 8-K on February 5, 2026 (AccNo: 0000926326-26-000003), disclosing results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard multi-item voluntary earnings-related disclosure with no directional financial data available.
05-02-2026
Tapestry, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001140361-26-003783), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard earnings-related disclosure without detailed performance data available.
- ·File size: 1 MB
- ·Sector: not specified
05-02-2026
Nathan's Famous, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001437749-26-003080), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be an informational earnings-related disclosure without detailed performance data.
- ·Event Type: Financial Results
- ·Source: us_sec
- ·Size: 491 KB
- ·Sector: NOT_DISCLOSED
05-02-2026
Hershey Co filed an 8-K on February 5, 2026 (AccNo: 0001628280-26-005604), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard earnings announcement filing with no detailed performance data available.
05-02-2026
Asbury Automotive Group Inc filed a Form 8-K on February 5, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a multi-item filing for financial results announcement. No specific revenue, earnings, guidance, or period-over-period metrics were disclosed in the provided filing information.
05-02-2026
KKR & Co. Inc. filed an 8-K on February 5, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons were mentioned in the provided filing details.
05-02-2026
SelectQuote, Inc. filed an 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided information. Detailed financial metrics and impacts remain NOT_DISCLOSED.
05-02-2026
Rockwell Automation, Inc. filed a Form 8-K on February 5, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional details available.
05-02-2026
Telomir Pharmaceuticals, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001493152-26-005199, Size: 208 KB), reporting under Item 8.01 Other Events. No specific details on the nature of the events, financial metrics, transactions, or impacts are disclosed in the provided filing summary. This is a voluntary, single-item disclosure with no quantitative data or period-over-period comparisons mentioned.
05-02-2026
Stellus Capital Investment Corp filed an 8-K on February 5, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the provided filing summary. No financial metrics, positive or negative changes, or period-over-period comparisons are mentioned.
05-02-2026
Estee Lauder Companies Inc filed an 8-K on February 5, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed financial data available.
05-02-2026
Artelo Biosciences, Inc. filed an 8-K on February 5, 2026, reporting solely under Item 8.01 Other Events. No specific details on the nature of the event, financial metrics, transactions, or impacts are disclosed in the provided filing metadata. Sector information is not specified.
- ·Accession Number: 0001640334-26-000221
- ·File Size: 145 KB
05-02-2026
FIDELITY D & D BANCORP INC filed an 8-K on February 5, 2026, disclosing under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or contents of the exhibits are provided in the filing summary. This multi-item filing appears informational with attached documents, but lacks quantitative metrics or directional indicators.
05-02-2026
INTELLIGENT BIO SOLUTIONS INC. filed a Form 8-K on February 05, 2026 (AccNo: 0001493152-26-005210), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing details. This represents a standard mandatory disclosure of financial results with attached exhibits.
05-02-2026
05-02-2026
Moleculin Biotech, Inc. filed a Form 8-K on February 5, 2026 (AccNo: 0001437749-26-003119), reporting under Item 5.07 the submission of matters to a vote of security holders following a shareholder meeting. No specific proposals, vote results, counts of votes (for, against, abstain, broker non-votes), or outcomes are disclosed in the provided information. This is a single-item mandatory filing with no financial metrics or quantitative data provided.
05-02-2026
Procaccianti Hotel REIT, Inc. filed a Form 8-K on February 5, 2026, under Item 8.01 reporting Other Events. No specific details regarding the nature of the event, financial impacts, transactions, or metrics are disclosed. This appears to be a single-item voluntary filing with no quantitative data provided.
05-02-2026
CleanSpark, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001193125-26-039382), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are explicitly stated in the provided filing details. This is a standard earnings-related disclosure without detailed performance data available.
05-02-2026
Arrow Electronics, Inc. filed an 8-K on February 5, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without extracted performance data.
05-02-2026
MIDDLEFIELD BANC CORP filed an 8-K on February 5, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details, transactions, financial metrics, or events are disclosed in the provided filing information.
05-02-2026
Oracle Corp filed an 8-K on February 5, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No specific details on the agreement, modifications, amendments, transaction values, financial impacts, or quantitative metrics are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or named entities provided.
05-02-2026
Artelo Biosciences, Inc. filed an 8-K on 2026-02-05 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), with exhibits under Item 9.01. No specific details on the agreement, transaction value, share counts, or financial impacts are disclosed. This is a multi-item mandatory filing with no period-over-period metrics or guidance provided.
05-02-2026
MONOLITHIC POWER SYSTEMS INC filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the leadership change, including key position affected, appointment or resignation status, reasons, timing, financial metrics, or performance comparisons, are NOT_DISCLOSED.
05-02-2026
QuidelOrtho Corp filed an 8-K on February 5, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including the key position affected, individuals involved, appointment or resignation status, reasons for the change, and any timing are NOT_DISCLOSED. No quantitative data, financial metrics, or further governance implications are provided in the filing summary.
05-02-2026
Simon Property Group Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, timing, or impacts are disclosed.
05-02-2026
JPMorgan Chase & Co filed an 8-K on February 5, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibit contents are disclosed in the provided filing information. This appears to be an informational filing without quantified positive or negative impacts.
05-02-2026
Angel Oak Mortgage REIT, Inc. filed an 8-K on February 05, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific financial metrics, transactions, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a voluntary disclosure with no further event details available.
05-02-2026
McCormick & Co Inc filed a Form 8-K on February 5, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or the content of the attached exhibits provided. Filing details include AccNo 0001193125-26-039410 and size 598 KB.
- ·AccNo: 0001193125-26-039410
- ·File size: 598 KB
- ·Event Type: General Filing
- ·Source: us_sec
05-02-2026
05-02-2026
Molina Healthcare, Inc. filed a Form 8-K on February 5, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.
05-02-2026
FEDERAL AGRICULTURAL MORTGAGE CORP filed an 8-K on 2026-02-05 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating voluntary disclosure of material non-public information per Regulation FD, with attached exhibits. No specific financial metrics, transactions, positive or negative changes, or other quantitative details are disclosed in the provided filing information.
- ·AccNo: 0000845877-26-000010
- ·File Size: 793 KB
- ·Sector: NOT_DISCLOSED
05-02-2026
Fidelity Wise Origin Bitcoin Fund filed a Form 8-K on February 5, 2026, disclosing entry into a material definitive agreement under Item 1.01 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, accompanied by financial statements and exhibits under Item 9.01. No specific details on the agreement, personnel changes, financial impacts, or quantitative metrics are provided in the available information. This multi-item filing appears informational without disclosed positive or negative performance metrics.
05-02-2026
Fidelity Ethereum Fund filed an 8-K on February 05, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed. This is a standard governance disclosure with no quantitative metrics or further context provided.
05-02-2026
Mobileye Global Inc. filed an 8-K on February 5, 2026, reporting under Item 3.02 regarding unregistered sales of equity securities. No quantitative details such as transaction value, share count, or parties involved were disclosed. This is a single-item mandatory disclosure with no additional financial or operational metrics provided.
05-02-2026
Fidelity Solana Fund filed an 8-K on February 5, 2026 (AccNo: 0001193125-26-039510), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any quantitative impacts are disclosed. Sector is not specified.
05-02-2026
Vivakor, Inc. filed a Form 8-K on 2026-02-05 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or performance metrics are disclosed.
05-02-2026
Limoneira CO filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.
05-02-2026
Nano Nuclear Energy Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 for Financial Statements and Exhibits. No specific details on the affected officer, position, reason for change, timing, or compensatory terms are disclosed.
05-02-2026
Stagwell Inc filed an 8-K on February 5, 2026, specifically under Item 3.02 disclosing unregistered sales of equity securities. No additional quantitative details, transaction values, share counts, parties involved, or financial impacts were mentioned in the filing information provided. This is a single-item filing with no positive or negative metrics reported.
05-02-2026
Kodiak Gas Services, Inc. filed a Form 8-K on February 05, 2026, disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. No specific details on the agreement, transaction size, financial impacts, or equity sales volumes are provided in the filing summary. This multi-item filing appears informational without quantified positive or negative metrics.
05-02-2026
Faraday Future Intelligent Electric Inc. filed a Form 8-K on February 5, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item mandatory disclosure with no specific details on the agreement terms, transaction size, or financial impacts provided. No positive or negative metrics, changes, or comparisons are disclosed.
05-02-2026
Wellgistics Health, Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals, reasons for changes, or quantitative impacts are disclosed.
05-02-2026
AMERICAN REBEL HOLDINGS INC filed a Form 8-K on February 5, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons were disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 55 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC